Robert Carter is an investor at Panda Biotech, with a transaction volume of $9.7 Million across 1 deal. Last deal was over 1 year ago for $9.7 Million.

Chairman and CEO

Robert Carter

Panda Biotech

Robert Carter at Panda Biotech: 1 deal, $10M volume on Traded. View commercial real estate transactions, pricing, and profile details.

Red Oak Capital Funds $9.7M Loan For Panda Biotech's Hemp Processing Facility In Wichita Falls